Jerrold Sendrow - 01 Jan 2023 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Issuer symbol
VRPX
Transactions as of
01 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 19:30:34 UTC
Previous filing
26 May 2022
Next filing
31 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 01 Jan 2023 Common Stock 35,000 $0.6220 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.